Who owns the SADA PRIT trademark?

The SADA PRIT trademark is owned by Y-mAbs Therapeutics, Inc.

What is the serial number for SADA PRIT?

The USPTO serial number for SADA PRIT is 79420192.

What is the registration number for SADA PRIT?

SADA PRIT is registered under USPTO registration number 8090719.

SAD

USPTO Trademark Record

REGISTERED

SADA PRIT

Q: What class is the SADA PRIT trademark registered in?

The SADA PRIT trademark is registered in Class 005 (Pharmaceuticals, medical & veterinary preparations), Class 042 (Scientific, technology & SaaS services).

SN 79420192·Reg 8090719·Filed Feb 04, 2025

Owner Y-mAbs Therapeutics, Inc

Pharmaceuticals, medical and veterinary preparations; sanitary preparations for medical purposes; dietetic food and substances adapted for medical or veterinary purposes, food for babies; dietary supplements for human beings and animals; adhesive plasters, materials for dressings; material for filling teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.; Scientific and technological services and research and design relating thereto; industrial analysis, industrial research and industrial design services; quality control and authentication services; design and development of computer hardware and software.

SADA PRIT (Serial No. 79420192), Registration No. 8090719, is a registered US trademark filed on Feb 04, 2025 by Y-mAbs Therapeutics, Inc. This trademark covers Class 005 (Pharmaceuticals, medical & veterinary preparations), Class 042 (Scientific, technology & SaaS services).

early section 8: January 06, 2032

Mark Intelligence

SADA PRIT (Reg. #8090719) is a registered US trademark that has been protecting its owner, Y-mAbs Therapeutics, Inc, since 2025. The mark covers Class 005 (Pharmaceuticals, medical & veterinary preparations) and Class 042 (Scientific, technology & SaaS services) respectively. Goods and services include Pharmaceuticals, medical and veterinary preparations; sanitary preparations for medical purposes; dietetic food and subs.... The mark faced 4 opposition proceedings during prosecution.

FILED

Feb 04, 2025

SERIAL

79420192

REG#

8090719

REGISTERED

Jan 06, 2026

Owner

Applicant

Y-mAbs Therapeutics, Inc

Entity

Corporation

State

Address

230 Park Avenue, Suite 3350

Country

Attorney

NameAndrew N. Spivak

Law firm

Andrew N. Spivak Mosaic Legal Group, PLLC

Docket

29515

Address

4300 Fordham Road, NW, Suite 250, Washington, DC 20016-1950, United States

Get pre-filing clearance

AI attorney analyzes your proposed mark against USPTO — Go/No-Go verdict, class-by-class risks, and strategy recommendations.

Run clearance

Filing Information

StatusREGISTERED

Filing DateFeb 04, 2025

Serial Number79420192

Registration No.8090719

Registration DateJan 06, 2026

Status DateJan 06, 2026

Published for OppositionNov 18, 2025

Mark TypeStandard characters

Attorney Docket29515

Status DescriptionLive and registered

Filing Signals

FILED

2025

YEARS AGO

CLASSES

MADRID FILINGS

—

Opposed 4× during prosecution

Search 14M+ trademarks

Free USPTO lookups by name, owner, or serial number. No account needed.

Search now

Full Goods & Services

CLASSES

OFFICE

USPTO

COUNTRY

Class 005Pharmaceuticals, medical & veterinary preparations

US codes: 005, 006, 018, 044, 046, 051, 052

Class 042Scientific, technology & SaaS services

US codes: 100, 101

Scientific and technological services and research and design relating thereto; industrial analysis, industrial research and industrial design services; quality control and authentication services; design and development of computer hardware and software.

This description is as filed with the USPTO and defines the scope of trademark protection.

Status History

31 events

NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB

Sep 10, 2026

NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB

NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB

Aug 26, 2026

NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB

NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB

Aug 26, 2026

NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB

FINAL DECISION TRANSACTION PROCESSED BY IB

Aug 06, 2026

FINAL DECISION TRANSACTION PROCESSED BY IB

FINAL DISPOSITION PROCESSED

Jul 16, 2026

FINAL DISPOSITION PROCESSED

FINAL DISPOSITION NOTICE SENT TO IB

Jul 16, 2026

FINAL DISPOSITION NOTICE SENT TO IB

FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB

Apr 06, 2026

FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB

REGISTERED-PRINCIPAL REGISTER

Jan 06, 2026

REGISTERED-PRINCIPAL REGISTER

NOTICE OF REGISTRATION CONFIRMATION EMAILED

Jan 06, 2026

NOTICE OF REGISTRATION CONFIRMATION EMAILED

NEW REPRESENTATIVE AT IB RECEIVED

Nov 20, 2025

NEW REPRESENTATIVE AT IB RECEIVED

PUBLISHED FOR OPPOSITION

Nov 18, 2025

PUBLISHED FOR OPPOSITION

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

Nov 18, 2025

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

REFUSAL PROCESSED BY IB

Nov 15, 2025

REFUSAL PROCESSED BY IB

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

Nov 12, 2025

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

TEAS/EMAIL CORRESPONDENCE ENTERED

Oct 22, 2025

TEAS/EMAIL CORRESPONDENCE ENTERED

APPROVED FOR PUB - PRINCIPAL REGISTER

Oct 22, 2025

APPROVED FOR PUB - PRINCIPAL REGISTER

TEAS RESPONSE TO OFFICE ACTION RECEIVED

Oct 20, 2025

TEAS RESPONSE TO OFFICE ACTION RECEIVED

CORRESPONDENCE RECEIVED IN LAW OFFICE

Oct 20, 2025

CORRESPONDENCE RECEIVED IN LAW OFFICE

NON-FINAL ACTION WRITTEN

Oct 16, 2025

NON-FINAL ACTION WRITTEN

TEAS RESPONSE TO OFFICE ACTION RECEIVED

Oct 15, 2025

TEAS RESPONSE TO OFFICE ACTION RECEIVED

CORRESPONDENCE RECEIVED IN LAW OFFICE

Oct 15, 2025

CORRESPONDENCE RECEIVED IN LAW OFFICE

TEAS/EMAIL CORRESPONDENCE ENTERED

Oct 15, 2025

TEAS/EMAIL CORRESPONDENCE ENTERED

REFUSAL PROCESSED BY IB

Sep 05, 2025

REFUSAL PROCESSED BY IB

REFUSAL PROCESSED BY MPU

Aug 19, 2025

REFUSAL PROCESSED BY MPU

NON-FINAL ACTION MAILED - REFUSAL SENT TO IB

Aug 19, 2025

NON-FINAL ACTION MAILED - REFUSAL SENT TO IB

NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW

Jul 15, 2025

NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW

ASSIGNED TO EXAMINER

Jul 14, 2025

ASSIGNED TO EXAMINER

NON-FINAL ACTION WRITTEN

Jul 14, 2025

NON-FINAL ACTION WRITTEN

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

Mar 31, 2025

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

APPLICATION FILING RECEIPT MAILED

Mar 31, 2025

APPLICATION FILING RECEIPT MAILED

SN ASSIGNED FOR SECT 66A APPL FROM IB

Mar 27, 2025

SN ASSIGNED FOR SECT 66A APPL FROM IB

SADA PRIT

Get pre-filing clearance

Search 14M+ trademarks

Run a conflict check

Other Marks by Y-mAbs Therapeutics, Inc

Other Marks in Class 005 — Pharmaceuticals, medical & veterinary preparations

Other Marks by Andrew N. Spivak

Resources

Company